740 related articles for article (PubMed ID: 34180979)
1. The β Cell in Diabetes: Integrating Biomarkers With Functional Measures.
Kahn SE; Chen YC; Esser N; Taylor AJ; van Raalte DH; Zraika S; Verchere CB
Endocr Rev; 2021 Sep; 42(5):528-583. PubMed ID: 34180979
[TBL] [Abstract][Full Text] [Related]
2. Islet amyloid polypeptide: a review of its biology and potential roles in the pathogenesis of diabetes mellitus.
O'Brien TD; Butler PC; Westermark P; Johnson KH
Vet Pathol; 1993 Jul; 30(4):317-32. PubMed ID: 8212454
[TBL] [Abstract][Full Text] [Related]
3. Islet amyloid: a complication of islet dysfunction or an aetiological factor in Type 2 diabetes?
Clark A; Nilsson MR
Diabetologia; 2004 Feb; 47(2):157-69. PubMed ID: 14722650
[TBL] [Abstract][Full Text] [Related]
4. Islet amyloid polypeptide: demonstration of mRNA in human pancreatic islets by in situ hybridization in islets with and without amyloid deposits.
Westermark GT; Christmanson L; Terenghi G; Permerth J; Betsholtz C; Larsson J; Polak JM; Westermark P
Diabetologia; 1993 Apr; 36(4):323-8. PubMed ID: 8477877
[TBL] [Abstract][Full Text] [Related]
5. Dual role of interleukin-1β in islet amyloid formation and its β-cell toxicity: Implications for type 2 diabetes and islet transplantation.
Park YJ; Warnock GL; Ao Z; Safikhan N; Meloche M; Asadi A; Kieffer TJ; Marzban L
Diabetes Obes Metab; 2017 May; 19(5):682-694. PubMed ID: 28058779
[TBL] [Abstract][Full Text] [Related]
6. Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes.
Hull RL; Westermark GT; Westermark P; Kahn SE
J Clin Endocrinol Metab; 2004 Aug; 89(8):3629-43. PubMed ID: 15292279
[TBL] [Abstract][Full Text] [Related]
7. Diabetes due to a progressive defect in beta-cell mass in rats transgenic for human islet amyloid polypeptide (HIP Rat): a new model for type 2 diabetes.
Butler AE; Jang J; Gurlo T; Carty MD; Soeller WC; Butler PC
Diabetes; 2004 Jun; 53(6):1509-16. PubMed ID: 15161755
[TBL] [Abstract][Full Text] [Related]
8. Tetracycline treatment retards the onset and slows the progression of diabetes in human amylin/islet amyloid polypeptide transgenic mice.
Aitken JF; Loomes KM; Scott DW; Reddy S; Phillips AR; Prijic G; Fernando C; Zhang S; Broadhurst R; L'Huillier P; Cooper GJ
Diabetes; 2010 Jan; 59(1):161-71. PubMed ID: 19794060
[TBL] [Abstract][Full Text] [Related]
9. Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes.
Kahn SE; Andrikopoulos S; Verchere CB
Diabetes; 1999 Feb; 48(2):241-53. PubMed ID: 10334297
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide.
Janson J; Soeller WC; Roche PC; Nelson RT; Torchia AJ; Kreutter DK; Butler PC
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7283-8. PubMed ID: 8692984
[TBL] [Abstract][Full Text] [Related]
11. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.
Westermark P; Andersson A; Westermark GT
Physiol Rev; 2011 Jul; 91(3):795-826. PubMed ID: 21742788
[TBL] [Abstract][Full Text] [Related]
12. [Islet amyloid and diabetes mellitus type 2].
Höppener JW; Nieuwenhuis MG; Vroom TM; Lips CJ
Ned Tijdschr Geneeskd; 2000 Oct; 144(42):1995-2000. PubMed ID: 11072517
[TBL] [Abstract][Full Text] [Related]
13. Amyloid in the islets of Langerhans: thoughts and some historical aspects.
Westermark P
Ups J Med Sci; 2011 May; 116(2):81-9. PubMed ID: 21486192
[TBL] [Abstract][Full Text] [Related]
14. Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid.
Butler AE; Janson J; Soeller WC; Butler PC
Diabetes; 2003 Sep; 52(9):2304-14. PubMed ID: 12941770
[TBL] [Abstract][Full Text] [Related]
15. Islet amyloid polypeptide in the islets of Langerhans: friend or foe?
Gebre-Medhin S; Olofsson C; Mulder H
Diabetologia; 2000 Jun; 43(6):687-95. PubMed ID: 10907112
[TBL] [Abstract][Full Text] [Related]
16. Banting lecture 1990. Beta-cells in type II diabetes mellitus.
Porte D
Diabetes; 1991 Feb; 40(2):166-80. PubMed ID: 1991568
[TBL] [Abstract][Full Text] [Related]
17. Long-term treatment with rosiglitazone and metformin reduces the extent of, but does not prevent, islet amyloid deposition in mice expressing the gene for human islet amyloid polypeptide.
Hull RL; Shen ZP; Watts MR; Kodama K; Carr DB; Utzschneider KM; Zraika S; Wang F; Kahn SE
Diabetes; 2005 Jul; 54(7):2235-44. PubMed ID: 15983227
[TBL] [Abstract][Full Text] [Related]
18. Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide.
Verchere CB; D'Alessio DA; Palmiter RD; Weir GC; Bonner-Weir S; Baskin DG; Kahn SE
Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3492-6. PubMed ID: 8622964
[TBL] [Abstract][Full Text] [Related]
19. Formation of islet amyloid fibrils in beta-secretory granules of transgenic mice expressing human islet amyloid polypeptide/amylin.
Yagui K; Yamaguchi T; Kanatsuka A; Shimada F; Huang CI; Tokuyama Y; Ohsawa H; Yamamura K; Miyazaki J; Mikata A
Eur J Endocrinol; 1995 Apr; 132(4):487-96. PubMed ID: 7711888
[TBL] [Abstract][Full Text] [Related]
20. Islet amyloid polypeptide (IAPP) and pancreatic islet amyloid deposition in diabetic and non-diabetic patients.
Narita R; Toshimori H; Nakazato M; Kuribayashi T; Toshimori T; Kawabata K; Takahashi K; Masukura S
Diabetes Res Clin Pract; 1992 Jan; 15(1):3-14. PubMed ID: 1541232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
